AI-Powered Universal IHC Continuous Quantification
Research Use Only. Not for use in diagnostic procedures
Maximize analysis of
next-gen protein biomarkers across
multiple cancer types
Request More InfoBenefits
Unlock next-generation IHC
biomarkers through advanced
feature identification
Apply AI to various targets in
multiple cancer types
Assess continuous staining
intensity, cell type identification,
and subcellular localization
Based on immunohistochemistry slide analysis,
Lunit SCOPE uIHC provides quantitative
analysis for precise target expression
across pan-cancer indications
Works on Any IHC Marker including:
- PD-L1
- HER2
- TROP2
- MUC16
- DLL3
- HER3
- FGFR2B
- CLDN 18.2
- MET
- E-CAD
Key Features
ADVANCED FEATURE ANALYSIS
AND QUANTIFICATION
Continuous staining
intensity quantification
(0-100%)
by each cell & location
1. Subcellular Localization
Membrane, Nuclear, Cytoplasm
2. Membrane Staining Pattern
Partial / Complete
3. Proximity Analysis
Cell distance relationships
FOR ANY TARGET ACROSS
MULTIPLE CANCER TYPES
uIHC AI
IHC Antibodies Across
Multiple Cancer Types
uIHC enables broader exploratory analysis in research, and additional feature characteristics and cutoffs for clinical development